AstraZeneca keeps generics off shelves ahead of appeal
Law360, London: Counsel for AstraZeneca convinced the Court of Appeal on 31 March 2025 to review a decision to let rival Glenmark release its generic version of a billion-dollar diabetes treatment under an agreement that the company can ship supplies of the drug already packed in trucks as long as it does not move ahead with retail sales in the meantime.